<DOC>
	<DOCNO>NCT02254291</DOCNO>
	<brief_summary>This trial conduct Japan . The purpose compare safety once-weekly dosing semaglutide ( 0.5 1.0 mg ) versus sitagliptin ( 100 mg ) daily , monotherapy 30 week treatment Japanese subject type 2 diabetes .</brief_summary>
	<brief_title>A Trial Comparing Safety Efficacy Semaglutide Once Weekly Versus Sitagliptin Once Daily Japanese Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Male female , age 20 year old time signing informed consent Glycated hemoglobin ( HbA1c ) 6.5 % 9.5 % ( 4880 mmol/mol ) ( inclusive ) subject treat oral antidiabetic drug ( OAD ) monotherapy 7.0 % 10.5 % ( 5391 mmol/mol ) ( inclusive ) subject treat diet exercise therapy screen Japanese subject diagnose type 2 diabetes : ) stable OAD monotherapy halfmaximum dose accord approved Japanese label addition diet exercise therapy least 30 day prior screen ( week 8 ) ( For metformin : maximum dose 750 mg/day allow except METGLUCO® . For METGLUCO® , allowable halfmax dose 1125 mg/day must applied. ) . 'Stable ' define unchanged medication unchanged dose , b ) stable diet exercise therapy least 30 day prior screen ( week 2 ) Female pregnant , breastfeed intend become pregnant childbearing potential use adequate contraceptive method ( e.g . abstinence , diaphragm , condom [ partner ] , intrauterine device , sponge , spermicide oral contraceptive ) throughout trial include 5week followup period Treatment onceweekly glucagonlike peptide1 ( GLP1 ) receptor agonist within 90 day prior screen Treatment glucose lower agent ( ) ( except pretrial OAD subject treat OAD monotherapy ) period 60 day prior screen . An exception shortterm treatment ( 7 day less total ) insulin connection intercurrent illness Any disorder , opinion investigator , might jeopardise subject 's safety compliance protocol History chronic idiopathic acute pancreatitis Screening calcitonin value 50 ng/L ( pg/mL ) great Personal family history medullary thyroid carcinoma ( MTC ) multiple endocrine neoplasia syndrome type 2 ( MEN2 ) Impaired renal function define estimate glomerular filtration rate ( eGFR ) less 60 ml/min/1.73 m^2 per modification diet renal disease ( MDRD ) formula ( 4 variable version ) Acute coronary cerebrovascular event within 90 day randomisation Heart failure , New York Heart Association ( NYHA ) class IV</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>